Concurrent Investment Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.03M Buy
19,596
+4,117
+27% +$2.08M 0.1% 229
2025
Q4
$8.77M Buy
15,479
+3,988
+35% +$2.12M 0.1% 216
2025
Q3
$5.14M Sell
11,491
-6,296
-35% -$3.02M 0.09% 234
2025
Q2
$9.67M Buy
17,787
+4,637
+35% +$2.42M 0.19% 115
2025
Q1
$6.51M Buy
13,150
+1,005
+8% +$556K 0.16% 138
2024
Q4
$6.34M Buy
12,145
+2,272
+23% +$1.18M 0.17% 123
2024
Q3
$4.85M Buy
9,873
+4,905
+99% +$2.28M 0.14% 151
2024
Q2
$2.21M Buy
4,968
+2,169
+77% +$864K 0.07% 248
2024
Q1
$1.12M Buy
2,799
+639
+30% +$241K 0.05% 354
2023
Q4
$728K Buy
+2,160
New +$644K 0.03% 401

Other funds holding ISRG

Concurrent Investment Advisors's ISRG Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Intuitive Surgical (ISRG) stake by 27% in Q1 2026, buying an estimated $2.08M and bringing the position to 19,596 shares worth $9.03M. The position accounts for 0.1% of the portfolio, ranked #229.

Concurrent Investment Advisors first reported a position in ISRG in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.67M in Q2 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Concurrent Investment Advisors held 19,596 shares of Intuitive Surgical worth $9.03M as of Q1 2026.
  • Concurrent Investment Advisors bought 4,117 Intuitive Surgical shares in Q1 2026, an estimated $2.08M.
  • Intuitive Surgical made up 0.1% of Concurrent Investment Advisors's portfolio in Q1 2026, its #229 holding.
  • Concurrent Investment Advisors first reported a position in Intuitive Surgical in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Intuitive Surgical position peaked at $9.67M in Q2 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.